ArrowMark Colorado Holdings’s Globus Medical GMED Stock Holding History

ArrowMark Colorado Holdings’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.1M	Sell	115,204 -372,222	-76%	-$31.6M	0.38%	101
2026 Q1	$42M	Sell	487,426 -353,599	-42%	-$31.7M	1.12%	21
2025 Q4	$73.4M	Sell	841,025 -361,463	-30%	-$27.4M	1.62%	5
2025 Q3	$68.9M	Buy	1,202,488 +241,236	+25%	+$13.9M	1.28%	19
2025 Q2	$56.7M	Buy	961,252 +162,469	+20%	+$10.5M	1.02%	32
2025 Q1	$58.5M	Buy	798,783 +211,157	+36%	+$17.4M	0.95%	36
2024 Q4	$48.6M	Sell	587,626 -26,669	-4%	-$2.1M	0.65%	50
2024 Q3	$43.9M	Buy	+614,295	New	+$43.4M	0.56%	56
2016 Q4	–	Sell	-112	Closed	-$3K	–	359
2016 Q3	$3K	Buy	+112	New	+$2.63K	﹤0.01%	352

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ArrowMark Colorado Holdings's GMED Position: Q2 2026 in Review

ArrowMark Colorado Holdings reduced its Globus Medical (GMED) stake by 76% in Q2 2026, selling an estimated $31.6M and leaving 115,204 shares worth $9.1M. The position accounts for 0.38% of the portfolio, ranked #101.

ArrowMark Colorado Holdings first reported a position in GMED in Q3 2016 and has held it in 9 quarters since. The position peaked at $73.4M in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

ArrowMark Colorado Holdings held 115,204 shares of Globus Medical worth $9.1M as of Q2 2026.
ArrowMark Colorado Holdings sold 372,222 Globus Medical shares in Q2 2026, an estimated $31.6M.
Globus Medical made up 0.38% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #101 holding.
ArrowMark Colorado Holdings first reported a position in Globus Medical in Q3 2016 and has held it in 9 quarters since.
ArrowMark Colorado Holdings's Globus Medical position peaked at $73.4M in Q4 2025.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.